An Assessment of Which Sociodemographic and Spinal Cord Injury–Specific Characteristics Influence Engagement With Experimental Therapies and Participation in Clinical Trials.

Background: Although a number of experimental therapies for spinal cord injury (SCI) have recently emerged, few authors have examined the goals of individuals with SCI considering experimental therapies, and none have determined whether sociodemographic and injury-specific characteristics influence...

Descripción completa

Detalles Bibliográficos
Publicado en:Topics in Spinal Cord Injury Rehabilitation Vol. 27; no. 4; pp. 28 - 40
Autores principales: Pazzi, Carlotta, Farrehi, Clara, Capron, Maclain, Anderson, Kim, Richardson, Bonnie, Stillman, Michael
Formato: research tables/charts Journal Article
Publicado: KnowledgeWorks Global, Ltd 2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=153651078&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 153651078
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10820744
        0OF
      jtl: Topics in Spinal Cord Injury Rehabilitation
      issn: 10820744
      maglogo: N
    pubinfo:
      dt: 2021
      vid: 27
      iid: 4
      pid: 81084
      pub: KnowledgeWorks Global, Ltd
      place: Richmond, Virginia
    artinfo:
      ui:
        153651078
        153651078
        153651078
        10.46292/sci20-00070
        153651078
      ppf: 28
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: An Assessment of Which Sociodemographic and Spinal Cord Injury–Specific Characteristics Influence Engagement With Experimental Therapies and Participation in Clinical Trials.
      aug:
        au:
          Pazzi, Carlotta
          Farrehi, Clara
          Capron, Maclain
          Anderson, Kim
          Richardson, Bonnie
          Stillman, Michael
        affil: Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania
      sug:
        subj:
          Spinal Cord Injuries Psychosocial Factors
          Socioeconomic Factors
          Clinical Trials
          Research Subjects
          Consumer Participation
          Human
          Male
          Female
          Middle Age
          Surveys
          Bowel and Bladder Management
          Autonomic Dysreflexia
          Access to Information
          Information Resources
          Descriptive Statistics
          Chi Square Test
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background: Although a number of experimental therapies for spinal cord injury (SCI) have recently emerged, few authors have examined the goals of individuals with SCI considering experimental therapies, and none have determined whether sociodemographic and injury-specific characteristics influence that engagement. Objectives: To determine (a) the goals of individuals with SCI who are considering experimental therapies; (b) whether sociodemographic factors, injury-specific characteristics, and concerns over adverse events influence those goals and/or participation in experimental therapies and clinical trials; and (c) whether people with SCI feel they have adequate information about experimental therapies and clinical trials. Methods: An online survey that yielded 364 responses. Results: Most respondents (83.7%) had sought information about experimental therapies, and just under half (47.8%) had received one. The most frequently cited functional goals were improvement in bowel and bladder function and elimination of dysreflexia (60.4%). Several goals were influenced by age and level and completeness of injury, and most respondents (93.4%) wanted more information about experimental therapies. Just over one-third (34.6%) of respondents had participated in a clinical trial, and nearly all (96.9%) wanted more information about them. Having received experimental therapies and participated in clinical trials was positively correlated with seeking SCI-specific care from an SCI specialist rather than from a primary care physician. Most (83.9%) respondents would avoid or be reluctant to engage with a medical center if they were made aware of harm done to trial participants. Conclusion: This work suggests that there are unmet information needs among people with SCI, specifically pertaining to experimental therapies and clinical trials. It also reveals that improved access to SCI specialists may enhance access to novel treatments and research efforts. Being made aware of harm to trial participants may influence the decision of individuals with SCI to seek care at or enroll in trials at these clinical sites.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N